Find comprehensive information on documenting and coding a history of aortic valve replacement. This resource covers clinical documentation improvement, ICD-10 codes (Z95.5), SNOMED CT, medical necessity guidelines, and best practices for accurately reflecting a patient's prior aortic valve surgery in electronic health records. Learn about different types of aortic valve replacements, including mechanical and bioprosthetic valves, and their implications for ongoing care. Explore resources for physicians, coders, and healthcare professionals seeking to ensure complete and compliant medical records related to a history of aortic valve replacement.
Also known as
Presence of artificial heart valve
Indicates a past aortic valve replacement.
Aortic valve stenosis
May be relevant if replacement was due to stenosis.
Aortic valve regurgitation
May be relevant if replacement was due to regurgitation.
Other aortic valve disorders
May be relevant if replacement was for other aortic valve issues.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the aortic valve still present?
When to use each related code
| Description |
|---|
| Aortic Valve Replacement |
| Aortic Stenosis |
| Aortic Regurgitation |
Coding Z95.5 (presence of cardiac prosthetic device) without specifying the type of valve replacement (mechanical, bioprosthetic, etc.) leads to inaccurate data.
Lack of sufficient documentation specifying the date of the aortic valve replacement procedure can hinder accurate coding and subsequent quality reporting.
Incorrectly coding complications related to the aortic valve replacement as the primary diagnosis instead of the history of the replacement itself.
Q: What are the key milestones in the history of aortic valve replacement (AVR) surgery, and how have these advancements impacted patient outcomes?
A: The history of aortic valve replacement (AVR) is marked by several key milestones. Early attempts in the 1950s involved homografts and xenografts, with limited durability. The development of the Starr-Edwards caged-ball mechanical valve in 1960 revolutionized AVR, offering a durable solution but requiring lifelong anticoagulation. Subsequent advancements led to the development of tilting-disc mechanical valves and bioprosthetic valves in the 1970s, offering improved hemodynamics and reduced thrombogenicity. The introduction of transcatheter aortic valve replacement (TAVR) in the 2000s marked a paradigm shift, providing a less invasive option for high-risk surgical patients. These advancements have significantly improved patient outcomes, including reduced mortality, morbidity, and recovery times. Explore how the evolution of AVR techniques has contributed to improved long-term survival and quality of life for patients with aortic valve disease.
Q: How do I differentiate between the various types of aortic valve prostheses available (mechanical, bioprosthetic, and TAVR valves), and what factors influence prosthesis selection for individual patients?
A: Choosing the optimal aortic valve prosthesis requires careful consideration of patient-specific factors. Mechanical valves offer excellent durability but necessitate lifelong anticoagulation, making them suitable for younger patients without contraindications to anticoagulants. Bioprosthetic valves, derived from animal tissue or human donors, have a limited lifespan but eliminate the need for long-term anticoagulation, making them preferable for older patients or those with bleeding risks. Transcatheter aortic valve replacement (TAVR) valves offer a less invasive approach for patients at high surgical risk, but valve durability and potential complications need to be considered. Factors influencing prosthesis selection include patient age, comorbidities, life expectancy, bleeding risk, lifestyle, and patient preference. Consider implementing a shared decision-making approach with patients to ensure informed consent and optimize prosthesis selection based on individual needs and preferences.
This patient presents with a history of aortic valve replacement (AVR). The original indication for surgery was [Specify original indication, e.g., severe aortic stenosis, aortic regurgitation, aortic root aneurysm]. The date of the AVR procedure was [Date]. The type of valve implanted was [Specify valve type, e.g., bioprosthetic, mechanical, transcatheter aortic valve replacement (TAVR)]. The specific valve model was [Specify valve model if known, e.g., Edwards Sapien 3, Medtronic CoreValve]. Current symptoms related to the aortic valve are [List current symptoms or specify "asymptomatic"]. The patient is currently prescribed [List current medications relevant to AVR, e.g., warfarin, aspirin, antiplatelet therapy]. Physical examination reveals [Describe pertinent cardiac findings, e.g., normal heart sounds, presence of a click, murmur]. Anticoagulation status is [Specify INR if applicable, therapeutic or subtherapeutic]. The patient's overall cardiac function is assessed as [e.g., New York Heart Association (NYHA) functional class]. Echocardiogram findings demonstrate [Summarize key findings, e.g., normal valve function, mean gradient, effective orifice area]. Plan includes [Describe follow-up plan, e.g., routine echocardiography, anticoagulation management, cardiology follow-up]. This patient's history of aortic valve replacement requires ongoing monitoring for potential complications including valve thrombosis, endocarditis, and structural valve deterioration. Patient education regarding medication adherence, signs and symptoms of complications, and the importance of follow-up care has been provided.